NYSE:OSK
NYSE:OSKMachinery

Is Oshkosh (OSK) Still Attractive After A 63% One Year Share Price Surge

If you are wondering whether Oshkosh is actually good value at its current share price, this article walks through the key numbers so you can judge that for yourself. The stock last closed at US$150.77, with returns of 6.4% over 7 days, 16.0% over 30 days, 14.0% year to date, 63.2% over 1 year, 70.4% over 3 years and 71.0% over 5 years, which puts recent valuation questions front and center. Recent headlines around Oshkosh have focused on its position in the capital goods space and investor...
NasdaqGS:VFS
NasdaqGS:VFSAuto

Assessing VinFast Auto (VFS) Valuation After Strong 2025 Delivery Progress And Ambitious Global Targets

VinFast’s latest delivery update and what it means for VFS stock VinFast Auto (VFS) reported preliminary Vietnam deliveries of 27,649 electric vehicles for December 2025 and 175,099 for the full year, building on guidance that 2025 global deliveries could approach 200,000 vehicles. See our latest analysis for VinFast Auto. These delivery updates arrive after a busy period for VinFast Auto. The company recently closed a US$470.6m shelf registration and issued fresh guidance that 2025 global EV...
NasdaqCM:MREO
NasdaqCM:MREOBiotechs

Why Mereo BioPharma (MREO) Is Up 69.9% After Mixed Setrusumab Phase 3 Results And Pipeline Shift

Mereo BioPharma Group recently reported that its Phase 3 Orbit and Cosmic trials of setrusumab in osteogenesis imperfecta missed their primary fracture reduction endpoints but achieved strong statistical improvements in bone mineral density, while also updating investors that its approximately US$41,000,000 cash balance at 31 December 2025 is expected to fund operations to mid-2027. Alongside reassessing the future of setrusumab with partner Ultragenyx, Mereo is pushing ahead with a single...
NasdaqGM:TTD
NasdaqGM:TTDMedia

Is Trade Desk (TTD) Price Near US$37 Misaligned With Its Cash Flow Potential

If you are trying to figure out whether Trade Desk shares offer fair value at around US$37.13, you are in the right place because this article focuses squarely on what that price might represent. The stock has seen mixed returns, with a 3.9% decline over the last 7 days, a 2.6% gain over 30 days, and longer term returns of 1.5% decline year to date, 69.0% decline over 1 year, 18.7% decline over 3 years, and 54.2% decline over 5 years. These moves sit against a backdrop of ongoing interest in...
NYSE:ALV
NYSE:ALVAuto Components

Is Autoliv (ALV) Attractive After Strong Multi Year Share Price Performance

If you are wondering whether Autoliv’s current share price lines up with its underlying value, this breakdown is designed to walk you through the key numbers that matter. Autoliv shares last closed at US$128.45, with returns of 4.2% over 7 days, 5.9% over 30 days, 5.2% year to date, 36.0% over 1 year and 71.8% over 3 years. This naturally raises questions about how much of this performance is already reflected in the price. Recent attention on Autoliv has centered on its position in vehicle...
NYSE:B
NYSE:BMetals and Mining

Is It Too Late To Reassess Barrick Mining (B) After Its 1 Year Surge?

If you are wondering whether Barrick Mining is still offering value at around US$49.95, you are not alone. The stock's recent run has many investors reassessing what a fair price looks like. The share price sits at US$49.95 after returns of 5.7% over 7 days, 15.3% over 30 days, 13.3% year to date, 222.0% over 1 year and 191.0% over 3 years, with a 5 year return of 141.7% putting those shorter term moves into a wider context. Recent coverage has focused on how Barrick Mining's performance and...
SWX:DKSH
SWX:DKSHTrade Distributors

Will SBTi-Validated Net-Zero Targets Redefine DKSH Holding's (SWX:DKSH) Long-Term Resilience Narrative?

DKSH Holding AG recently received official validation from the Science Based Targets initiative that its near-term and net-zero emissions targets align with climate science and the Paris Agreement, confirming deep reductions in Scope 1, 2, and 3 emissions and a commitment to net-zero across its value chain by 2050. This independent endorsement strengthens DKSH’s sustainability positioning, underscoring how its efforts in transport optimization, renewable electricity, fleet electrification,...
NYSE:THC
NYSE:THCHealthcare

Is Tenet Healthcare (THC) Still Attractive After A 265% Three Year Share Price Surge

If you are wondering whether Tenet Healthcare's current share price reflects its underlying worth, you are not alone. This article is built to help you think through that question calmly and clearly. The stock last closed at US$195.19, with a 1 year return of 50.1% and a 3 year return of 265.4%. Shorter term moves have been softer, with a 7 day return of a 3.4% decline, a 30 day return of a 1.1% decline, and a year to date return of a 2.1% decline. Recent attention on Tenet Healthcare has...
XTRA:FRA
XTRA:FRAInfrastructure

Should Weather‑Driven Cancellations at Frankfurt Test the Resilience of Fraport’s (XTRA:FRA) Traffic Model?

Earlier this week, Frankfurt Airport, operated by Fraport, cancelled more than one hundred of roughly 1,050 scheduled flights due to severe snow and ice, with Germany’s weather service issuing frost warnings and passengers advised to check flight status in advance. The disruption cut January visitor numbers to Germany by an estimated ten to fifteen percent, underlining how weather-related operational risks can quickly affect Fraport’s traffic volumes and tourism-linked revenues. With...
TSX:OGC
TSX:OGCMetals and Mining

Is OceanaGold (TSX:OGC) Quietly Repositioning Its Mining Portfolio As A Core S&P Player?

Recently, OceanaGold Corporation was highlighted for its strength within Canada’s materials sector and its solid positioning in the S&P Composite Index, reflecting market recognition of its gold and copper operations across multiple regions. This sector-level outperformance within the index draws attention to how investors are responding to OceanaGold’s role in the broader mining value chain relative to peers. Building on this recognition within the S&P Composite Index, we’ll examine how it...
NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Is Mobileye (MBLY) Turning Its ADAS Chip Wins Into a Durable Platform Advantage?

Earlier this month, Mobileye announced that a US-based automaker selected its EyeQ6H chip to power future hands-free Surround ADAS on millions of vehicles globally, adding an estimated 9 million units to more than 19 million projected EyeQ6H-based systems. The deal underlines how Mobileye’s vertically integrated, software-defined Surround ADAS platform, leveraging up to 11 sensors and REM crowdsourced data, is being positioned as a standard feature across mainstream and premium models as...
SWX:ROG
SWX:ROGPharmaceuticals

Is Roche Holding (SWX:ROG) Pricing Fully Reflects Strong Multi‑Year Share Performance

If you are wondering whether Roche Holding's current share price really reflects its quality and prospects, you are not alone; many investors are asking the same question. The stock last closed at CHF 345.70, with returns of 1.9% over 7 days, 7.9% over 30 days, 6.2% year to date, 33.0% over 1 year and 31.0% over 3 years. This naturally raises questions about how much of this performance is already priced in. Recent coverage has focused on Roche Holding's position as a major global...
TSX:ENB
TSX:ENBOil and Gas

Is Enbridge (TSX:ENB) Offering Value After Recent Share Price Gains?

If you are wondering whether Enbridge is fairly priced or offering value right now, its recent track record gives you plenty to think about before you make any decisions. The stock last closed at C$64.66, with a 3.1% gain over the past 7 days, a 1.5% decline over 30 days, a 2.1% decline year to date, and a 7.9% return over 1 year, alongside 41.8% and 99.8% returns across the last 3 and 5 years. Recent coverage has focused on Enbridge's role as a major North American energy infrastructure...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Assessing Palantir Technologies (PLTR) Valuation After Strong Long Term Returns And Choppy Recent Trading

Palantir Technologies: recent performance snapshot Palantir Technologies (PLTR) has drawn attention after a period where the stock showed a 0.3% one day decline and small negative moves over the past week and month, alongside modestly positive year to date and past 3 months returns. Against this share price backdrop, investors are also watching fundamentals. These include reported annual revenue of US$3.9b and net income of US$1.1b, together with the company’s current value score of 0. See...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

Assessing CrowdStrike Holdings (CRWD) Valuation After Recent Share Price Weakness And Strong Multi Year Returns

Context for CrowdStrike Holdings (CRWD) Investors CrowdStrike Holdings (CRWD) shares have been moving without a clear single news catalyst, which can make recent performance and valuation feel harder to interpret for you as an investor. Over the past month, the stock shows a return of about a 5.7% decline, with a roughly 4.9% decline over the past 3 months and a small gain year to date. That mix of short term weakness and a positive 1 year total return of about 26.8% raises natural questions...
TSE:5078
TSE:5078Real Estate

CEL (TSE:5078) EPS Slide To ¥51.95 Reinforces Bearish Earnings Narrative

CEL (TSE:5078) has released its Q3 2026 results, reporting revenue of ¥4,581 million and basic EPS of ¥51.95 for the quarter as investors weigh the latest numbers against a longer stretch of softer earnings. The company’s quarterly revenue has moved from ¥6,810 million in Q2 2025 to ¥4,581 million in Q3 2026, while basic EPS has shifted from ¥166.58 to ¥51.95 over the same period. Trailing twelve month EPS now stands at ¥342.69 on revenue of ¥22,185 million, with net margins at 5.2%. See our...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Is Teladoc’s Data‑Driven 24/7 Care Upgrade Quietly Reframing Its Integrated Care Story (TDOC)?

Earlier this month, Teladoc Health launched nationwide enhancements to its long-running 24/7 Care virtual urgent care service, expanding treatable conditions, integrating specialist consults, using claims and Health Information Exchange data for preventive care, and enabling real-time prescription benefit checks. A distinctive aspect of this update is the use of integrated data and on-the-spot specialist input to resolve most issues within a single visit while prompting many patients to act...